The move toward value-based reimbursement is not only no guarantee of financial catastrophe, but the experience could even be a financially positive one, hospital CFOs say.
This article appears in the July/August 2015 issue of HealthLeaders magazine.
Many hospital CEOs and CFOs have been forced to straddle the two worlds of fee-for-service and value-based reimbursements for some time now, even if their organizations largely held to the more familiar approach and hoped others would show how to thrive when putting revenue at risk. As more healthcare systems are joining—or being swept along—in the movement toward increased bundled-payment and shared-savings contracts, those early adopters are revealing their secrets to success.
Their message is largely reassuring: You can move toward value-based reimbursement without any catastrophic effect on revenue. The whole experience could even be a positive one financially, they say.
SOURCE: http://healthleadersmedia.com/content/FIN-319951/ValueBased-Reimbursement-is-Not-a-Revenue-Killer
